The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Multimodality Therapy for Locally Advanced Cervical Carcinoma: State of the Art and Future Directions
Abstract
Globally, cervical cancer is the second most common cause of cancer-related mortality among women causing approximately 234,000 deaths annually among developing countries and killing 40,000 in developed nations. Most of these deaths occur in women with bulky or locally advanced cervical cancer, International Federation of Gynecology and Obstetrics (FIGO) stages IIB through IVA, when lesions are not amenable to high cure rates with surgery or radiation (RT). The standard prescription for RT used to treat locally advanced cervical cancer has been dictated by common practice and patterns of care studies. In contrast, the addition of concomitant chemotherapy to RT has been studied in a number of randomized prospective trials, which are discussed in detail. When added to RT, cisplatin reduces the relative risk of death from cervical carcinoma by approximately 50% by decreasing local/pelvic failure and distant metastases. In 1999, weekly intravenous cisplatin at 40 mg/m 2 for 6 weeks in combination with RT was established as a new standard for the treatment of locally advanced cervical carcinoma. More recently, this recommendation has been expanded to include women with FIGO stage IB2 lesions as well as those with bulky stage IIA cancers. This monograph reviews the state of the art in treating locally advanced cervical cancer with combined chemotherapy and RT and discusses clinical and pathologic prognostic factors that impact cure. Quality of life during and after multimodality therapy is considered as well as ongoing clinical trials and future directions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
Rose, P. G., Bundy, B. N., Watkins, E. B., Thigpen, J. T., Deppe, G., Maiman, M. A., Clarke-Pearson, D. L., & Insalaco, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401502 · Cited by 2,658
Morris, M., Eifel, P. J., Lu, J., Grigsby, P. W., Levenback, C., Stevens, R. E., Rotman, M., Gershenson, D. M., & Mutch, D. G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401501 · Cited by 2,299
Peters, W. A., Liu, P. Y., Barrett, R. J., Stock, R. J., Monk, B. J., Berek, J. S., Souhami, L., Grigsby, P., Gordon, W., & Alberts, D. S. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1606 · Cited by 2,284
Self-citationKeys, H. M., Bundy, B. N., Stehman, F. B., Muderspach, L. I., Chafe, W. E., Suggs, C. L., Walker, J. L., & Gersell, D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401503 · Cited by 1,923
Whitney, C. W., Sause, W., Bundy, B. N., Malfetano, J. H., Hannigan, E. V., Fowler, Jr., Clarke-Pearson, D. L., & Liao, S.-Y. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1339 · Cited by 1,524
Sedlis, A., Bundy, B. N., Rotman, M. Z., Lentz, S. S., Muderspach, L. I., & Zaino, R. J. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5387 · Cited by 1,315
Benedet, J. L. (2000) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(00)00300-3 · Cited by 1,104
Eifel, P. J., Winter, K., Morris, M., Levenback, C., Grigsby, P. W., Cooper, J., Rotman, M., Gershenson, D., & Mutch, D. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.197 · Cited by 1,018
(2000) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(00)90001-8 · Cited by 891
Rotman, M., Sedlis, A., Piedmonte, M. R., Bundy, B., Lentz, S. S., Muderspach, L. I., & Zaino, R. J. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.10.019 · Cited by 604
QUINN, M., BENEDET, J., ODICINO, F., MAISONNEUVE, P., BELLER, U., CREASMAN, W., HEINTZ, A., NGAN, H., & PECORELLI, S. (2006) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(06)60030-1 · Cited by 563
Nag, S., Erickson, B., Thomadsen, B., Orton, C., Demanes, J. D., & Petereit, D. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00497-1 · Cited by 560
Benedet, J. L., Odicino, F., Maisonneuve, P., Beller, U., Creasman, W. T., Heintz, A. P. M., Ngan, H. Y. S., & Pecorelli, S. (2003) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(03)90115-9 · Cited by 455
Kosary, C. L. (1994) · Seminars in Surgical Oncology · doi:10.1002/ssu.2980100107 · Cited by 417
Pearcey, R. G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.966 · Cited by 370
Greimel, E. R., Kuljanic Vlasic, K., Waldenstrom, A., Duric, V. M., Jensen, P. T., Singer, S., Chie, W., Nordin, A., Bjelic Radisic, V., Wydra, D., et al. (2006) · Cancer · doi:10.1002/cncr.22217 · Cited by 319
Mitchell, D. G., Snyder, B., Coakley, F., Reinhold, C., Thomas, G., Amendola, M., Schwartz, L. H., Woodward, P., Pannu, H., & Hricak, H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.4799 · Cited by 310
Pearcey, R., Brundage, M., Drouin, P., Jeffrey, J., Johnston, D., Lukka, H., MacLean, G., Souhami, L., Stuart, G., & Tu, D. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.4.966 · Cited by 288
FDG-PET for management of cervical and ovarian cancer
Havrilesky, L. J., Kulasingam, S. L., Matchar, D. B., & Myers, E. R. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.12.007 · Cited by 253
Quality of life in long-term cervical cancer survivors
Wenzel, L., DeAlba, I., Habbal, R., Kluhsman, B. C., Fairclough, D., Krebs, L. U., Anton-Culver, H., Berkowitz, R., & Aziz, N. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.01.010 · Cited by 248
Varia, M. A., Bundy, B. N., Deppe, G., Mannel, R., Averette, H. E., Rose, P. G., & Connelly, P. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00267-3 · Cited by 220
Monk, B. J., Wang, J., Im, S. S., Stock, R. J., Peters, W. A., Liu, P. Y., Barrett, R. J., Berek, J. S., Souhami, L., Grigsby, P. W., et al. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.11.007 · Cited by 206
Self-citationKöhler, C., Klemm, P., Schau, A., Possover, M., Krause, N., Tozzi, R., & Schneider, A. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.07.025 · Cited by 198
Lanciano, R., Calkins, A., Bundy, B. N., Parham, G., Lucci, J. A., Moore, D. H., Monk, B. J., & O'Connor, D. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.0497 · Cited by 197
Self-citationA critical review of patient-rated quality of life studies of long-term survivors of cervical cancer
Vistad, I., Fosså, S. D., & Dahl, A. A. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.03.050 · Cited by 195
Vaccines Against Human Papillomavirus and Cervical Cancer: Promises and Challenges
Mahdavi, A., & Monk, B. J. (2005) · The Oncologist · doi:10.1634/theoncologist.10-7-528 · Cited by 123
Self-citationMoore, D. H. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000215986.48590.79 · Cited by 117
Thomas, G., Dembo, A. J., Ackerman, I., Franssen, E., Balogh, J. M., Fyles, A., & Levin, W. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.4990 · Cited by 104
Monk, B. J., Tian, C., Rose, P. G., & Lanciano, R. M. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.12.027 · Cited by 98
Self-citationChemoradiotherapy in the Treatment of Cervical Cancer
Eifel, P. J. (2006) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2006.02.007 · Cited by 96
Syed, A. M. N., Puthawala, A. A., Abdelaziz, N. N., et al. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02900-0 · Cited by 95
Stehman, F. B., Bundy, B. N., Thomas, G., Keys, H. M., dʼAblaing, G., Fowler, W. C., Mortel, R., & Creasman, W. T. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.8.1523 · Cited by 91
Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer
Wong, L. C., Choo, Y. C., Choy, D. T. K., Sham, J., & K., H. (1989) · Gynecologic Oncology · doi:10.1016/0090-8258(89)90035-8 · Cited by 88
Craighead, P. S., Pearcey, R. G., & Stuart, G. C. E. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00720-3 · Cited by 82
Leborgne, F. E., Leborgne, J., Doldán, R., Zubizarreta, E., Ortega, B., Maisonneuve, J., Musetti, E., Hekimian, L., & Mezzera, J. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00491-9 · Cited by 81
Waggoner, S. E., Darcy, K. M., Fuhrman, B. J., Parham, G. P., Lucci, J. A., Monk, B. J., & Moore, D. H. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.05.017 · Cited by 72
Self-citationStehman, F. B., Bundy, B. N., Keys, H. M., Currie, J. L., Mortel, R., & Creasman, W. T. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90499-1 · Cited by 65
Gaffney, D. K., Winter, K. A., Dicker, A. P., Miller, B. E., Eifel, P. J., Ryu, J. K., Avizonis, V. N., Fromm, M., & Greven, K. M. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.08.002 · Cited by 62
Hydroxyurea and radiation therapy in advanced cervical cancer
Piver, M. S., Barlow, J. J., Vongtama, V., & Webster, J. H. (1974) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(74)90347-0 · Cited by 60
Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervix
Piver, M. S., Barlow, J. J., Vongtama, V., & Blumenson, L. E. (1977) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(77)90580-4 · Cited by 60
Lavey, R. S., Liu, P. Y., Greer, B. E., Robinson, W. R., Chang, P. C., Wynn, R. B., Conrad, M. E., Jiang, C. S., Markman, M. M., & Alberts, D. S. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.07.009 · Cited by 58
Piver, M. S., Khalil, M., & Emrich, L. J. (1989) · Journal of Surgical Oncology · doi:10.1002/jso.2930420211 · Cited by 56
Ashing‐Giwa, K. T., PADILLA, G. V., Bohorquez, D. E., Tejero, J. S., Garcia, M., & Meyers, E. A. (2006) · Journal of Psychosocial Oncology · doi:10.1300/j077v24n04_04 · Cited by 40
Temkin, S. M., Hellmann, M., Serur, E., et al. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00709.x · Cited by 32
Anders, J. C., Grigsby, P. W., & Singh, A. K. (2006) · Radiation Oncology · doi:10.1186/1748-717x-1-14 · Cited by 31
Russell, A. H., Shingleton, H. M., Jones, W. B., Fremgen, A. M., M.D., D. P. W., Clive, R. E., & Chmiel, J. S. (1996) · Gynecologic Oncology · doi:10.1006/gyno.1996.0300 · Cited by 29
Monk, B. J., & Tewari, K. S. (2007) · Elsevier eBooks · doi:10.1016/b978-032303978-9.50006-x · Cited by 25
Self-citationLin, A., Ryu, J. K., Harvey, D. J., et al. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.11.031 · Cited by 19
Chemotherapy in the management of cervical carcinoma.
duPont, N. C., & Monk, B. J. (2006) · PubMed · Cited by 14
Self-citation
Cited by
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Tewari, K. S., Sill, M. W., Long, H. J., Penson, R. T., Huang, H., Ramondetta, L. M., Landrum, L. M., Oaknin, A., Reid, T. J., Leitao, M. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1309748 · Cited by 1,504
Self-citationCervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Koh, W.-J., Abu-Rustum, N. R., Bean, S., Bradley, K., Campos, S. M., Cho, K. R., Chon, H. S., Chu, C., Clark, R., Cohn, D., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0001 · Cited by 1,054
Self-citationCarcinogenic human papillomavirus infection
Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999
Self-citationMonk, B. J., Sill, M. W., McMeekin, D. S., Cohn, D. E., Ramondetta, L. M., Boardman, C. H., Benda, J., & Cella, D. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.8909 · Cited by 693
Self-citationTewari, K. S., Sill, M. W., Penson, R. T., Huang, H., Ramondetta, L. M., Landrum, L. M., Oaknin, A., Reid, T. J., Leitao, M. M., Michael, H. E., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31607-0 · Cited by 684
Self-citation
Metadata
- Authors
- Monk, B. J., Tewari, K. S., & Koh, W.-J.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-07-10
- Volume
- 25
- Issue
- 20
- Pages
- 2952-2965
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2131538171
- Cited by
- 261
- References
- 51
- FWCI
- 12.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.